Ciba-geigy Corporation

Novartis Corporation

Bayer Corporation

Alex Alder

Daniel Bellus

Steven Mark Barnard

Jaroslav Stanek

Joseph Berger

Marcus Baumann

Say-Jong Law

Anand Natrajan

Qingping Jiang

David J Sharpe

Adrian Waldner

Peter Flury

Rolf Hilfiker

Alfred Rindlisbacher

Marizel Rouilly

Hans-Peter Streibert

Jun Xi

Rudolf Banninger

Nils Blom

Erika Schmidt

Jaroslaw Stanek

Paul Senn

Fritz Thommen

A new class of chemiluminescent acridinium or benzacridinium compounds is disclosed by virtue of forming an intramolecular energy transfer conjugate (ETC) between the acridinium or benzacridinium compound and a luminophore. A method of extending the emission wavelengths of acridinium or benzacridinium esters in order to further reduce or eliminate the emission spectral overlap between the parent polysubstituted aryl Acridinium Esters (DMAE) and Benzacridinium Esters (LEAE) is disclosed. The ETC's retain the unique desired properties of acridinium or benzacridinium compounds including complete light emission in very short period of time, monophasic emission spectrum, simplicity of triggering mechanism, ability of labeling the biological molecules of interest to form a tracer, and good stability. Additionally, the range of the emission spectrum of an acridinium or benzacridinium compound can now be shifted at will and at longer leap through the choice of a luminophore as the integral part of an ETC molecule. Disclosed are chemiluminescent labeled conjugates comprising an acridinium or benzacridinium moiety covalently attached to a luminophore via a spacer, said moiety further conjugated to a biological molecule of interest, wherein said spacer is of an appropriate length to allow the excited species generated from said moiety to transfer energy efficiently to said luminophore, resulting in the emission of light in the spectral region of said luminophore. Also disclosed are binding assays using said conjugates, test kits comprising said conjugates and methods of preparing the conjugates.

Chemiluminescent energy transfer conjugates and their uses as labels in

Optical sensor for the determination of ions

Optical sensor system for determining pH values and ionic strengths

The reaction of 5,6,11,12-tetrachlorotetracene with thiourea and sulfur in a polar aprotic solvent yields 5,6,11,12-tetrathiotetracene in high yield and purity. This compound is an electron donor for forming electrically conductive radical cation salts with electron donors.

Process for the preparation of 5,6,11,12-tetrathiotetracene

The insecticidal and acaricidal activity of N-phenylthioureas can be enhanced and prolonged by the simultaneous application of photosensitizers, and this activity can also be effected within a shorter period of time after application.

Pesticidal compositions with enhanced activity

The photooxidation of N,N'-substituted thioureas with oxygen in the presence of an acid-trapping agent gives N,N'-substituted carbodiimides. The carbodiimides can be converted into cyanoguanidines, which are suitable as latent curing agents for epoxy resins.

Process for the preparation of carbodiimides

Compounds of the formula I ##STR1## in which R.sup.1, R.sup.2, R.sup.3 and R.sup.4 are, for example, H, alkyl, cycloalkyl, aryl or alkaryl are suitable as an ammonium salt-forming component for acid pharmaceutical active ingredients, and in particular for the preparation of azabicyclo[3.1.1.]heptane-substituted alkanediphosphonic acids for the treatment of diseases which can be attributed to disturbances in calcium metabolism.

Azabicycloheptanes and process for their preparation

Curable epoxy resin compositions containing cyanoguanidines of formula I ##STR1## wherein, for example, R.sup.1 and R.sup.2 are phenyl, as latent hardeners, have good properties and are especially suitable for use as laminating resins.

Cyanoguanidines as hardeners for epoxy resins

1-Phenyl-3-azabicyclo[3.1.1]-heptane-2,4-diones of the formula ##STR1## in which R.sub.1 represents hydrogen or a saturated or unsaturated, aliphatic, cycloaliphatic, cycloaliphatic-aliphatic, aromatic or aromatic-aliphatic hydrocarbon radical having up to and including 18, preferably up to and including 12, carbon atoms, R.sub.2 represents hydrogen, lower alkyl, sulpho or acyl, R.sub.3 represents hydrogen or lower alkyl and R.sub.4 represents hydrogen, lower alkyl, phenyl or phenyl substituted by --N(R.sub.2)(R.sub.3), and salts of these compounds, have valuable pharmacological properties, are effective as aromatase inhibitors and can therefore be used for the treatment of hormone-dependent diseases, especially mammary carcinoma.

Certain 1-phenyl-cyclobutane-1,3-dicarboxylic acid type compounds

1-phenyl-3-azabicyclo[3.1.1]-heptane-2,4-diones of the formula ##STR1## in which R.sub.1 represents hydrogen or a saturated or unsaturated, aliphatic, cycloaliphatic, cycloaliphatic-aliphatic, aromatic or aromatic-aliphatic hydrocarbon radical having up to and including 18, preferably up to and including 12, carbon atoms, R.sub.2 represents hydrogen, lower alkyl, sulpho or acyl, R.sub.3 represents hydrogen or lower alkyl and R.sub.4 represents hydrogen, lower alkyl, phenyl or phenyl substituted by --N(R.sub.2)(R.sub.3), and salts of these compounds, have valuable pharmacological properties, are effective as aromatase inhibitors and can therefore be used for the treatment of hormone-dependent diseases, especially mammary carcinoma.

Substituted azabicycloheptanes, the use thereof, pharmaceutical

Substituted-3-azabicyclo[3.1.1]heptane-2,4-diones useful for treating

Growing community of inventors

Arisdorf, Switzerland

Alex Alder